title: Inflammatory mediators involved in the progression of the metabolic syndrome.
abstract: The metabolic syndrome is often associated with type 2 diabetes mellitus, dyslipidemia, atherosclerosis, hypertension, steatosis of the liver and other organs, as well as hypertension, type 2 diabetes mellitus, and atherosclerosis. Recent studies have implicated a number of inflammatory mediators including cytokines, adipokines and eicosanoids in the inflammatory responses that accompany the metabolic syndrome. Measurements of the circulating levels of the inflammatory molecules that accompany this syndrome might provide leads to therapeutic approaches to modulate the inflammatory responses and thereby alter disease progression. In this review, we summarize recent studies on classical and newer inflammatory mediators in the pathogenesis of the metabolic syndrome in humans and experimental models.
authors.affiliation: The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. jancemkf@163.com
authors.forename: Kuifen
authors.initials: K
authors.lastname: Ma
authors.forename: Xi
authors.initials: X
authors.lastname: Jin
authors.forename: Xingguang
authors.initials: X
authors.lastname: Liang
authors.forename: Qingwei
authors.initials: Q
authors.lastname: Zhao
authors.forename: Xingguo
authors.initials: X
authors.lastname: Zhang
mesh_terms: D048909:Diabetes Complications / Q000209:etiology / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000503:physiopathology; D018450:Disease Progression; D006801:Humans; D007249:Inflammation / Q000209:etiology / Q000378:metabolism*; D018836:Inflammation Mediators / Q000378:metabolism*; D024821:Metabolic Syndrome / Q000209:etiology / Q000378:metabolism*
chemical_list: D018836:Inflammation Mediators